Immune

Thymosin Alpha-1

Controlled trials

A 28-amino-acid thymic peptide with genuine clinical use.

SubQIntermediateApproved outside the USimmune supportinflammationlongevityrecovery and sleep

Also known as Tα1 · Ta1 · Thymalfasin · Zadaxin

At a glance

Dose summary

Typical dose1.6 mg
Range800 mcg–3.2 mg
Frequency2×/week
Half-life~2 h
ScheduleTwice a week
Cycle length8 weeks
RouteSubQ
Experience levelIntermediate
Evidence gradeControlled trials
ApprovalApproved outside the US
Where the dose comes fromAn approved product label

Reconstitution

What to draw, at the usual vial

A 10 mg vial reconstituted with 2 mL of bacteriostatic water gives 5.00 mg/mL. A typical 1.6 mg dose is 0.320 mL — pull the plunger to 32 units on a U-100 syringe.

Concentration5.00 mg/mL
Draw volume0.320 mL
U-100 units32 units
Doses per vial6

Same dose, other vial sizes

VialWaterConcentrationDrawUnitsDoses
1.60 mg2 mL0.80 mg/mL2.000 mL200 units1
5 mg2 mL2.50 mg/mL0.640 mL64 units3
10 mg2 mL5.00 mg/mL0.320 mL32 units6

The highlighted row is the one quoted above: the smallest listed vial that holds at least four typical doses. Change any of it — a different vial, more or less water, a different dose — on the reconstitution calculator, which draws the syringe to true U-100 graduations.

Mechanism & evidence

What it is, and what is known

A 28-amino-acid thymic peptide with genuine clinical use. Marketed as thymalfasin (Zadaxin) and approved in a number of countries outside the US for chronic hepatitis B and C and as a vaccine adjuvant; it is NOT FDA approved. The best-established regimen is the labeled one: 1.6 mg subcutaneously twice weekly, which is where the typical dose here comes from. Higher daily dosing has been studied in sepsis and in hospitalised COVID-19 patients, which is the basis for the upper end of the range; that is an acute inpatient context, not a wellness protocol.

Approved hepatitis courses run 24 weeks or longer, so the 8-week cycle shown here reflects common non-clinical use rather than the label. Reported plasma half-life is roughly 2 hours, but its immunological effect outlasts plasma levels.

The caveat

Marketed as thymalfasin and approved in several countries outside the US, but not FDA approved. The labeled hepatitis courses run far longer than the cycle shown here.

Tolerability

Reported side effects

  • Injection site discomfort, redness or transient swelling
  • Short-lived flu-like feeling or fatigue after a dose
  • Muscle aches
  • Rare rash

Hard stops

Do not use this if

  • Pregnancy, possible pregnancy, or breastfeeding
  • Under 18

These are flags, not a screening. They do not replace a conversation with a clinician who knows your history.

Handling

Storage

Sealed powder, refrigerated24 months
After reconstitution, refrigerated30 days

Keep it cold, keep it dark, and label the vial with the date you mixed it. Discard anything cloudy or past the window above.

Combinations

Commonly stacked with

Stacking multiplies the side-effect surface and makes it impossible to tell which compound did what. Add one thing at a time.

References

Sources

Educational information only, not medical advice. Talk to a licensed clinician before starting, changing, or stopping anything.